Kestrel Mazurek

Kestrel Mazurek is a seasoned Senior Scientist with extensive experience in analytical chemistry, specializing in oligonucleotides and method development. Currently at Switch Therapeutics, Kestrel oversees projects and leads an eight-person chemistry R&D team. Previous roles include Senior Scientist at Switchback Systems, where Kestrel established an analytical lab and developed HPLC and LCMS methods, and Scientist at Synthego Corporation, focusing on LC/MS systems for oligonucleotides. Earlier career highlights include positions at Life Technologies, Covalent Industrial Technologies, and Agorics, Inc., encompassing various aspects of analytical chemistry, synthesis, and technical writing. Kestrel holds a BA in Chemistry from Reed College.